Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2020-10-01

FDA Approved: CANASA — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental labeling/approval for CANASA (mesalamine) from Allergan, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CANASA (Mesalamine)

Snippet

SUPPL AP for CANASA (MESALAMINE)